相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care
Susan A. Olender et al.
CLINICAL INFECTIOUS DISEASES (2021)
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
Shruti Gupta et al.
JAMA INTERNAL MEDICINE (2021)
COVID-19-neutralizing antibodies predict disease severity and survival
Wilfredo F. Garcia-Beltran et al.
CELL (2021)
Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence
Hui Xian Jaime Lin et al.
INFECTION (2021)
The place for remdesivir in COVID-19 treatment
Barnaby Young et al.
LANCET INFECTIOUS DISEASES (2021)
Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 Seroconversion and Viral Clearance in Patients Hospitalized With COVID-19: Viral Load Predicts Antibody Response
Mar Masia et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Mortality Benefit of Remdesivir in COVID-19: A Systematic Review and Meta-Analysis
Vikas Bansal et al.
FRONTIERS IN MEDICINE (2021)
Biases in Evaluating the Safety and Effectiveness of Drugs for the Treatment of COVID-19: Designing Real-World Evidence Studies
Christel Renoux et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2021)
Major Update: Remdesivir for Adults With COVID-19: A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points
Anjum S. Kaka et al.
ANNALS OF INTERNAL MEDICINE (2021)
A real-life setting evaluation of the effect of remdesivir on viral load in COVID-19 patients admitted to a large tertiary centre in Israel
Elad Goldberg et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials
Ahmad Al-Abdouh et al.
CONTEMPORARY CLINICAL TRIALS (2021)
Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis
Afra Rezagholizadeh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19
Brian T. Garibaldi et al.
JAMA NETWORK OPEN (2021)
Remdesivir therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
Charan Thej Reddy Vegivinti et al.
ANNALS OF MEDICINE AND SURGERY (2021)
Clinical outcomes of different therapeutic options for COVID-19 in two Chinese case cohorts: A propensity-score analysis
Carlos K. H. Wong et al.
ECLINICALMEDICINE (2021)
Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study
Pablo Monedero et al.
CRITICAL CARE (2021)
Remdesivir and its antiviral activity against COVID-19: A systematic review
Andri Frediansyah et al.
CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH (2021)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D. Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19
Matthew R. Davis et al.
INFECTIOUS DISEASES AND THERAPY (2020)
A minimal common outcome measure set for COVID-19 clinical research
J. C. Marshall et al.
LANCET INFECTIOUS DISEASES (2020)
Drug treatments for covid-19: living systematic review and network meta-analysis
Reed A. C. Siemieniuk et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial
Christoph D. Spinner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score
Stephen R. Knight et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis
Alejandro Piscoya et al.
PLOS ONE (2020)
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19
Kening Li et al.
NATURE COMMUNICATIONS (2020)
Multiple imputation using chained equations: Issues and guidance for practice
Ian R. White et al.
STATISTICS IN MEDICINE (2011)
Some Methods of Propensity-Score Matching had Superior Performance to Others: Results of an Empirical Investigation and Monte Carlo simulations
Peter C. Austin
BIOMETRICAL JOURNAL (2009)